A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/24/2002	US20020155174 Acidified nitrite as an antimicrobial agent
10/24/2002	US20020155167 Self-setting calcium phosphate pastes and related products
10/24/2002	US20020155161 Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
10/24/2002	US20020155160 For therapy of thrombotic condition and reducing the time required for reperfusion of an occluded blood vessel
10/24/2002	US20020155158 For controlled, prolonged release of bioactive molecules such as therapeutic proteins, peptides and oligonucleotides
10/24/2002	US20020155156 For forming controlled release formulation of a therapeutic agent; for coating solid dosage
10/24/2002	US20020155155 Method of fabricating a banded prolonged release active agent dosage form
10/24/2002	US20020155154 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
10/24/2002	US20020155153 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
10/24/2002	US20020155152 Membrane structure
10/24/2002	US20020155151 For therapy of diseases of the cardiovascular system, lung, muscles, stomach and bowels (ulcer and gastritis), diabetes, skin, nerves, tinnitus, in degenerative metabolic imbalance, incontinence, periodontosis, mitochondrial diseases
10/24/2002	US20020155149 Iodophor compositions
10/24/2002	US20020155146 Liquid crystalline polymers
10/24/2002	US20020155145 Biofunctional polymers prepared in supercritical fluid
10/24/2002	US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002	US20020155141 Pharmacologically acceptable solvent vehicles
10/24/2002	US20020155137 To form cements, fillers, growth matrices, orthopedic and delivery devices; resorbable and stimulate hard tissue growth and healin; useful as human or animal implantable bioceramics
10/24/2002	US20020155129 Simple non-toxic system, deliverable by syringe or needle-free systems, is inexpensive and reliable and aids in parenteral drug delivery or mass immunization campaigns by reducing need for repeated injections
10/24/2002	US20020155103 Activated charcoal based composition and method for reducing hangover symptomps associated with the consumption of alcohol containing beverages
10/24/2002	US20020155102 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells
10/24/2002	US20020155092 For producing articles useful for implantation or injection into the human body
10/24/2002	US20020155084 Nanoemulsion formulations
10/24/2002	US20020155076 Cosmetic or dermatological application
10/24/2002	US20020155069 Applying treatment products simultaneously to a localized area of human body as a function of characteristics of localized area and/or of predetermined design, in order to obtain a mixture of treatment products directly on localized area
10/24/2002	US20020155068 Inhalatory compositions of formoterol
10/24/2002	US20020155067 For drug delivery
10/24/2002	US20020155066 For pulmonary administration of highly toxic or vesicating anticancer drugs
10/24/2002	US20020153509 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
10/24/2002	US20020153508 Cubic liquid crystalline compositions and methods for their preparation
10/24/2002	DE10061932A1 New process for the preparation of microparticles, useful e.g. for controlled drug release, comprises encapsulating active agent in biodegradable polymer under heating, cooling and milling in two stages to a fine powder
10/24/2002	DE10061136C1 Stable, rapidly disintegrating tablets containing proton pump inhibitors, useful for treating elevated gastric secretion, comprising multiple drug units and auxiliaries including basic filler
10/24/2002	CA2455274A1 Animal model for evaluating analgesics
10/24/2002	CA2447008A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002	CA2444761A1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2444421A1 Modification of the sustained release profile
10/24/2002	CA2444268A1 Gastric acid secretion inhibiting composition comprising an acid susceptible proton pump inhibitor and an h2 receptor antagonist
10/24/2002	CA2444267A1 Prodrugs of cox-2 inhibitors
10/24/2002	CA2444220A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/24/2002	CA2443912A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto
10/24/2002	CA2443639A1 Compositions containing imidazotriazinone for nasal application
10/24/2002	CA2443563A1 Nail compositions and methods of administering same
10/24/2002	CA2443559A1 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application
10/24/2002	CA2443473A1 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
10/24/2002	CA2443471A1 An effervescent solid composition of matter
10/24/2002	CA2443468A1 Pharmaceutical product with reticulated crystalline microstructure
10/24/2002	CA2443464A1 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
10/24/2002	CA2443461A1 Pharmaceutical formulations containing anti-inflammatory active ingredients and the use of said formulations
10/24/2002	CA2443242A1 Improvements in or relating to modified cellulose films
10/24/2002	CA2442626A1 Articles comprising a mint odor-free cooling agent
10/23/2002	WO2001095940A1 Sustained release compositions
10/23/2002	EP1251142A1 Use of copolymers based on acrylamidoalkylenesulphonic acid as thickener in compositions containing an organic solvent
10/23/2002	EP1250941A1 Articles comprising a mint odor-free cooling agent
10/23/2002	EP1250937A2 Controlled dissolution of active ingredients
10/23/2002	EP1250936A1 Use of starch for transdermal applications
10/23/2002	EP1250933A1 Vaccines including as an adjuvant high dose type I IFN
10/23/2002	EP1250932A1 A stable aqua formulation of interferon, the preparation method and the uses thereof
10/23/2002	EP1250927A2 Pharmaceutical composition for topical application comprising nifedipine
10/23/2002	EP1250926A2 Use of a water-insoluble S-camptothecin with a closed lactone ring in the manufacture of a medicament for treatment of colon cancer
10/23/2002	EP1250925A2 Nasal spray containing ondansetron hydrochloride
10/23/2002	EP1250924A1 Eye drops
10/23/2002	EP1250922A1 Rolled external-use patch
10/23/2002	EP1250921A1 Fast disintegrating meloxicam tablet
10/23/2002	EP1250920A1 Unloaded ion exchange resins for the extended release of active ingredients
10/23/2002	EP1250916A1 An emulsifying agent without peg and their use for the preparation at room temperature of cosmetic, phaceutical and dermatological compositions
10/23/2002	EP1250359A1 Chitosan condensation products, their preparation and their uses
10/23/2002	EP1250350A2 Novel crystalline composites comprising phytosterols and phytostanols or derivatives thereof
10/23/2002	EP1250347A1 Antisense modulation of akt-3 expression
10/23/2002	EP1250343A1 Azalide antibiotic compositions
10/23/2002	EP1250321A1 Glyburide composition
10/23/2002	EP1250189A1 Method for modifying the surfaces of fine-porous adsorbents
10/23/2002	EP1250166A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia
10/23/2002	EP1250161A2 Polymer blends as biodegradable matrices for preparing biocomposites
10/23/2002	EP1250151A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
10/23/2002	EP1250143A2 Reduction in bacterial colonization by administering bacteriophage compositions
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250138A1 Fulvestrant formulation
10/23/2002	EP1250133A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/23/2002	EP1250132A1 Ibuprofen containing active agent preparation
10/23/2002	EP1250130A1 Propofol formulation with enhanced microbial inhibition
10/23/2002	EP1250127A1 A method of administering a medicinal aerosol formulation
10/23/2002	EP1250126A2 Transepithelial delivery of glp-1 derivatives
10/23/2002	EP1250125A2 Pharmaceutical compositions comprising terbinafine
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1250056A1 Composition for intestinal delivery
10/23/2002	EP1250053A2 Method for produce sanitation using bacteriophages
10/23/2002	EP1250050A2 Method and device for sanitation using bacteriophages
10/23/2002	EP1250045A2 Particulate blends and compacted products formed therefrom, and the preparation thereof
10/23/2002	EP1159966B1 Composition for the treatment of psoriasis
10/23/2002	EP1144009B1 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/23/2002	EP1107734B1 Oral liquid mucoadhesive compositions
10/23/2002	EP1009380B1 Method for preparing pharmaceutical formulations
10/23/2002	EP0994727B1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
10/23/2002	EP0977626B1 Composition based on alkylpolyglycosides and fatty alcohols, and uses thereof
10/23/2002	EP0885014B1 Pharmaceutical compositions containing buffered ortho ester polymers
10/23/2002	EP0844269B1 Block copolymer having functional groups at both ends
10/23/2002	EP0843547B1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
10/23/2002	EP0822217B1 Heterotelechelic block copolymers and process for producing the same
10/23/2002	EP0804241B1 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds
10/23/2002	EP0754037A4 Methods of administering n-substituted benzamides or phenothiazines

1 ... 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 ... 2991